Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Wrapup Of The Big Kahuna Confab. More details...
Including Private and Public Companies. More details...
Biotech Makes A Big Gain. More details...
CBT 200 Gives Back Half Of Monday's Gain. More details...
CBT 200 Down 34 Points In Late Slide. More details...
Biogen Idec/Elan Drug Faces Advisory Committee. More...
Company Markets Plasma Products. More details...
CBT 200 Gains 1.4%. More details...
CBT 200 Scores A Win. More details...
CBT 200 Takes a 46 Point Tumble. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
